insulin human
Sponsors
Novo Nordisk A/S, Medical University of Graz, Nordsjaellands Hospital, Columbia University, Khyber Teaching Hospital
Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Dry EyeHealthyHyperinsulinemiaInsulin ResistanceInsulin Sensitivity
Phase 1
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
CompletedNCT01269606
Start: 2011-01-31End: 2011-03-31Updated: 2014-06-16
Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
CompletedNCT01511159
Start: 2001-10-31End: 2001-12-31Updated: 2015-03-26
Pancreatic Clamp in NAFLD
CompletedNCT05724134
Start: 2023-08-29End: 2025-09-24Updated: 2026-01-12
Dexamethasone/Pancreatic Clamp P&F
WithdrawnNCT06126354
Start: 2024-07-01End: 2026-03-31Updated: 2024-07-10
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Not yet recruitingNCT06558422
Start: 2027-01-01End: 2029-02-28Target: 36Updated: 2026-02-06
Phase 2
Phase 3
Phase 4
Unknown Phase
NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
CompletedNCT01492205
Start: 2005-09-30End: 2006-06-30Updated: 2016-10-14
Observational Study With InnoLet® in Daily Clinical Practice
CompletedNCT01492959
Start: 2004-03-23End: 2005-03-23Updated: 2017-02-28
Changing Diabetes in Children
TerminatedNCT02382757
Start: 2011-09-30End: 2012-11-30Updated: 2015-03-09
Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes
NCT05095259
Start: 2019-12-16End: 2023-12-31Target: 60Updated: 2023-05-03